NCT07025304View on ClinicalTrials.gov

Post-Market Clinical Study to Evaluate the Safety and Effectiveness of REFLEX ULTRA 45 for Coblation Inferior Turbinate Reduction in China

NARecruitingINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

July 2, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

June 30, 2028

Conditions
Nasal Obstruction Due to Inferior Turbinate Hypertrophy
Interventions
DEVICE

REFLEX ULTRA 45

One time use for surgery

Trial Locations (6)

130033

RECRUITING

China-Japan Union Hospital of Jilin University, Changchun

210003

NOT_YET_RECRUITING

Jiangsu Province Hospital, Nanjing

310016

NOT_YET_RECRUITING

Sir Run Run Shaw Hospital Affiliated with Zhejiang University School of Medicine, Hangzhou

462000

NOT_YET_RECRUITING

Henan Provincial People's Hospital, Zhengzhou

510080

NOT_YET_RECRUITING

The First Affiliated Hospital, Sun Yat-sen University, Guangzhou

510630

NOT_YET_RECRUITING

The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou

All Listed Sponsors
lead

Smith & Nephew, Inc.

INDUSTRY

NCT07025304 - Post-Market Clinical Study to Evaluate the Safety and Effectiveness of REFLEX ULTRA 45 for Coblation Inferior Turbinate Reduction in China | Biotech Hunter | Biotech Hunter